Cortecs International Ltd. commenced trading its AmericanDepositary Receipts (ADRs) on the NASDAQ small-cap stockmarket on Wednesday. The London company's ADRs will tradeunder the symbol DLVRY.
Cortecs develops new delivery systems for pharmaceuticals.For trading, one ADR will represent five shares of commonstock. Cortecs has 74.9 million common shares, of which theADRs constitute approximately 5 percent.
(c) 1997 American Health Consultants. All rights reserved.